ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

REVB Revelation Biosciences Inc

2.20
0.09 (4.27%)
25 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -1.86M-1.2M-1.22M-1.62M-1.93M-2.78M-2.33M-1.9M
Pre Tax Income -1.83M-1.17M-1.21M6.16M-1.45M-2.63M-2.2M-2.68M
Net Income -1.83M-1.17M-1.21M6.16M-1.45M-2.63M-2.2M-2.68M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -1.83M-1.18M-1.21M-1.59M-1.87M-2.72M-2.27M-2.75M
EBITDA -1.85M-1.19M-1.21M-1.61M-1.93M-2.77M-2.32M-1.9M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -4k-145k-3.09M-10.87M-8.66M
Pre Tax Income -4k-136k-2.13M-10.83M-120k
Net Income -4k-136k-2.13M-10.83M-120k
Preferred Dividends 00000
Basic Earnings Per Share (EPS) 0-0.054-1.171-15.857-0.019
EBIT -4k-145k-3.09M-10.83M-8.45M
EBITDA -4k-145k-3.09M-10.84M-8.63M